AKT1 and breast carcinoma: Interestingly, the combination of XPO1 and tamoxifen blocked the activation of the AKT signalling pathway, induced autophagy, improved the treatment sensitivity to tamoxifen and reshaped the tumour metabolic pathway, which provided a new approach for the future treatment of breast cancer.133, 134